HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparisons of once-daily nilvadipine with enalapril and diuretic in patients with essential hypertension.

Abstract
The antihypertensive efficacy of the new dihydropyridine derivative nilvadipine given once daily was compared in two randomized, double-blind studies with that of hydrochlorothiazide/triamterene (HCT/T) and of enalapril. In the first study, arterial pressures were compared after 4 weeks of therapy with nilvadipine (16 mg q.d.) or HCT/T (25/50 mg q.d.) in patients with mild-to-moderate hypertension in a parallel-group design. The combination of both treatments was administered after 4 weeks if diastolic arterial pressures were > 90 mm Hg. The blood pressure (BP) in the nilvadipine group (n = 125) was 161/102 +/- 17/7 (mean +/- SD) mm Hg after a 2-week placebo period and decreased after 4 weeks by -16/-13 +/- 22/12 mm Hg. The BP decreased in the HCT/T group (n = 124) compared to the nilvadipine group to a similar degree (p = 0.91, n.s.) from 160/103 +/- 17/8 mm Hg by -17/-13 +/- 18/11 mm Hg. A combination therapy was started after 4 weeks in 39 patients in the nilvadipine group and in 34 patients in the HCT/T group. This led independently of the treatment sequence, to a similar decrease in BP in the nilvadipine group (-17/7 +/- 16/10 mm Hg) and in the HCT/T group (-12/9 +/- 16/9 mm Hg). In the second study, the antihypertensive effect of nilvadipine (1 x .8 mg) was compared with that of enalapril (1 x 10 mg) in a randomized, double-blind, crossover design. Sixty-one patients with essential hypertension (WHO I-II) were treated over two 4-week periods following placebo periods of 2 weeks.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsE Fritschka
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 20 Suppl 6 Pg. S62-8 ( 1992) ISSN: 0160-2446 [Print] United States
PMID1283192 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Antihypertensive Agents
  • nilvadipine
  • Hydrochlorothiazide
  • Enalapril
  • Nifedipine
  • Triamterene
Topics
  • Antihypertensive Agents (administration & dosage, therapeutic use)
  • Blood Pressure (drug effects)
  • Double-Blind Method
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Drug Tolerance
  • Enalapril (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Hydrochlorothiazide (administration & dosage)
  • Hypertension (drug therapy)
  • Male
  • Middle Aged
  • Nifedipine (administration & dosage, analogs & derivatives, therapeutic use)
  • Triamterene (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: